Soleno Therapeutics Inc’s recent filing unveils that its CHIEF EXECUTIVE OFFICER Anish Bhatnagar unloaded Company’s shares for reported $3.14 million on Aug 06 ’24. In the deal valued at $45.46 per share,69,131 shares were sold. As a result of this transaction, Anish Bhatnagar now holds 856,190 shares worth roughly $42.4 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Mackaness James H sold 8,134 shares, generating $369,736 in total proceeds. Upon selling the shares at $45.46, the CHIEF FINANCIAL OFFICER now owns 140,780 shares.
Before that, Hirano Patricia C sold 5,977 shares. Soleno Therapeutics Inc shares valued at $271,689 were divested by the insider at a price of $45.46 per share. As a result of the transaction, Hirano Patricia C now holds 122,745 shares, worth roughly $6.08 million.
Robert W. Baird initiated its Soleno Therapeutics Inc [SLNO] rating to an Outperform in a research note published on May 10, 2024; the price target was $72. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in early February with a ‘”an Overweight”‘ rating. Stifel began covering SLNO with “Buy” recommendation on January 23, 2024.
Price Performance Review of SLNO
On Tuesday, Soleno Therapeutics Inc [NASDAQ:SLNO] saw its stock jump 5.72% to $49.52. Over the last five days, the stock has gained 5.97%. Soleno Therapeutics Inc shares have risen nearly 23.03% since the year began. Nevertheless, the stocks have risen 942.53% over the past one year. While a 52-week high of $53.82 was reached on 02/28/24, a 52-week low of $3.69 was recorded on 01/04/24. SMA at 50 days reached $44.86, while 200 days put it at $41.05.
Levels Of Support And Resistance For SLNO Stock
The 24-hour chart illustrates a support level at 47.64, which if violated will result in even more drops to 45.75. On the upside, there is a resistance level at 50.83. A further resistance level may holdings at 52.13. The Relative Strength Index (RSI) on the 14-day chart is 58.14, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.39, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 14.19%. Stochastics%K at 59.49% indicates the stock is a holding.
How much short interest is there in Soleno Therapeutics Inc?
A steep rise in short interest was recorded in Soleno Therapeutics Inc stocks on
The most recent change occurred on September 29, 2020 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.
